Mir O - Search Results

1

Comparative transplacental transfer of taxanes using the human perfused cotyledon placental model.

Berveiller P, Vinot C, Mir O, Broutin S, Deroussent A, Seck A, Camps S, Paci A, Gil S, Tréluyer JM. Berveiller P, et al. Among authors: mir o. Am J Obstet Gynecol. 2012 Dec;207(6):514.e1-7. doi: 10.1016/j.ajog.2012.10.007. Epub 2012 Oct 8. Am J Obstet Gynecol. 2012. PMID: 23174392

2

Transplacental transfer of oseltamivir and its metabolite using the human perfused placental cotyledon model.

Berveiller P, Mir O, Vinot C, Bonati C, Duchene P, Giraud C, Gil S, Treluyer JM. Berveiller P, et al. Among authors: mir o. Am J Obstet Gynecol. 2012 Jan;206(1):92.e1-6. doi: 10.1016/j.ajog.2011.07.023. Epub 2011 Jul 22. Am J Obstet Gynecol. 2012. PMID: 21958869

3

Use of platinum derivatives during pregnancy.

Mir O, Berveiller P, Ropert S, Goffinet F, Goldwasser F. Mir O, et al. Cancer. 2008 Dec 1;113(11):3069-74. doi: 10.1002/cncr.23935. Cancer. 2008. PMID: 18985677 Free article. Review.

4

A dramatic fetal outcome following transplacental transfer of dasatinib.

Berveiller P, Andreoli A, Mir O, Anselem O, Delezoide AL, Sauvageon H, Chapuis N, Tsatsaris V. Berveiller P, et al. Among authors: mir o. Anticancer Drugs. 2012 Aug;23(7):754-7. doi: 10.1097/CAD.0b013e328352a8fe. Anticancer Drugs. 2012. PMID: 22421368

5

Cancer and pregnancy: an overview for obstetricians and gynecologists.

Berveiller P, Carbonne B, Mir O. Berveiller P, et al. Among authors: mir o. Am J Obstet Gynecol. 2014 Jul;211(1):82. doi: 10.1016/j.ajog.2014.02.007. Epub 2014 Feb 11. Am J Obstet Gynecol. 2014. PMID: 24530817 No abstract available.

6

[Tyrosine kinase inhibitors and pregnancy: A risk to the fetus?].

Jovelet C, Broutin S, Gil S, Mir O, Paci A. Jovelet C, et al. Among authors: mir o. Bull Cancer. 2016 May;103(5):478-83. doi: 10.1016/j.bulcan.2016.02.001. Epub 2016 Mar 8. Bull Cancer. 2016. PMID: 26969425 Review. French.

7

Use of anticancer agents in gynecological oncology during pregnancy: a systematic review of maternal pharmacokinetics and transplacental transfer.

Berveiller P, Marty O, Vialard F, Mir O. Berveiller P, et al. Among authors: mir o. Expert Opin Drug Metab Toxicol. 2016 May;12(5):523-31. doi: 10.1517/17425255.2016.1167187. Epub 2016 Apr 4. Expert Opin Drug Metab Toxicol. 2016. PMID: 27020922 Review.

8

Chemotherapy in pregnancy: exploratory study of the effects of paclitaxel on the expression of placental drug transporters.

Berveiller P, Mir O, Degrelle SA, Tsatsaris V, Selleret L, Guibourdenche J, Evain-Brion D, Fournier T, Gil S. Berveiller P, et al. Among authors: mir o. Invest New Drugs. 2019 Oct;37(5):1075-1085. doi: 10.1007/s10637-018-0677-7. Epub 2018 Oct 26. Invest New Drugs. 2019. PMID: 30367323

9

Increased evidence for use of chemotherapy in pregnancy.

Mir O, Berveiller P. Mir O, et al. Lancet Oncol. 2012 Sep;13(9):852-4. doi: 10.1016/S1470-2045(12)70331-5. Epub 2012 Aug 16. Lancet Oncol. 2012. PMID: 22902484 No abstract available.

10

Taxanes during pregnancy: probably safe, but still to be optimized.

Berveiller P, Mir O. Berveiller P, et al. Among authors: mir o. Oncology. 2012;83(4):239-40. doi: 10.1159/000341820. Epub 2012 Aug 16. Oncology. 2012. PMID: 22907122 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters